Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids.

Baek, C H

Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids. [electronic resource] - Transplantation proceedings Apr 2019 - 749-760 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial

1873-2623

10.1016/j.transproceed.2019.01.057 doi


Adrenal Cortex Hormones--administration & dosage
Adult
Cyclosporine--therapeutic use
Delayed-Action Preparations--therapeutic use
Female
Glomerular Filtration Rate
Graft Rejection--prevention & control
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--administration & dosage
Kidney Transplantation
Male
Middle Aged
Patient Satisfaction
Republic of Korea
Research Design
Tacrolimus--administration & dosage
Transplant Recipients